Effect of cellular microenvironment and paracrine signals on chondrogenic differentiation of mesenchymal progenitor cells

Stem Cell, Regenerative Medicine and Cancer

Volumn , Issue , 2011, Pages 441-466

  Grässel, Susanne ^a   Dreier, Rita ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895401281     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (113)

1. Hunziker, EB. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage, 2002, 10, 432-463.
2. Buckwalter, JA; Mankin, HJ; Grodzinsky, AJ. Articular cartilage and osteoarthritis. Instr. Course Lect, 2005, 54, 465-480.
3. Friedenstein, AJ; Gorskaja, JF; Kulagina, NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol, 1976, 4, 267-274.
4. Pittenger, MF; Mackay, AM; Beck, SC; Jaiswal, RK; Douglas, R; Mosca, JD; Moorman, MA; Simonetti, DW; Craig, S; Marshak, DR. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284, 143-147.
5. Cancedda, R; Dozin, B; Giannoni, P; Quarto, R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol, 2003, 22, 81-91.
6. Caplan, AI. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng, 2005, 11, 1198-1211.
7. Phinney, DG; Hill, K; Michelson, C; DuTreil, M; Hughes, C; Humphries, S; Wilkinson, R; Baddoo, M; Bayly, E. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. Stem Cells, 2006, 24, 186-198.
8. Grassel, S; Ahmed, N; Gottl, C; Grifka, J. Gene and protein expression profile of naive and osteo-chondrogenically differentiated rat bone marrow-derived mesenchymal progenitor cells. Int. J. Mol. Med, 2009, 23, 745-755.
9. Phinney, DG ; Prockop, DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells, 2007, 25, 2896-2902.
10. Uccelli, A; Moretta, L; Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol, 2008, 8, 726-736.
11. Wu, JJ; Woods, PE; Eyre, DR. Identification of cross-linking sites in bovine cartilage type IX collagen reveals an antiparallel type II-type IX molecular relationship and type IX to type IX bonding. J. Biol. Chem, 1992, 267, 23007-23014.
12. Mackie, EJ; Ahmed, YA; Tatarczuch, L; Chen, KS; Mirams, M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int. J. Biochem. Cell Biol, 2008, 40, 46-62.
13. Linsenmayer, TF; Toole, BP; Trelstad, RL. Temporal and spatial transitions in collagen types during embryonic chick limb development. Dev. Biol, 1973, 35, 232-239.
14. DeLise, AM; Fischer, L; Tuan, RS. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage, 2000, 8, 309-334.
15. Reddi, AH. Bone and cartilage differentiation. Curr Opin Genet Dev, 1994, 4, 737-744.
16. Cancedda, R; Descalzi, CF; Castagnola, P. Chondrocyte differentiation. Int. Rev. Cytol, 1995, 159, 265-358.
17. Farjanel, J; Schurmann, G; Bruckner, P. Contacts with fibrils containing collagen I, but not collagens II, IX, and XI, can destabilize the cartilage phenotype of chondrocytes. Osteoarthritis Cartilage, 2001, 9 Suppl A, S55-S63.
18. O'Driscoll, SW; Fitzsimmons, JS. The role of periosteum in cartilage repair. Clin. Orthop. Relat. Res, 2001, 391 Suppl, S190-S207.
19. Ito, Y; Fitzsimmons, JS; Sanyal, A; Mello, MA; Mukherjee, N; O'Driscoll, SW. Localization of chondrocyte precursors in periosteum. Osteoarthritis Cartilage, 2001, 9, 215-223.
20. Yin, T ; Li, L. The stem cell niches in bone. J. Clin. Invest, 2006, 116, 1195-1201.
21. Dorshkind, K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu. Rev. Immunol, 1990, 8, 111-137.
22. Uccelli, A; Pistoia, V; Moretta, L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol, 2007, 28, 219-226.
23. Ducy, P; Schinke, T; Karsenty, G. The osteoblast: a sophisticated fibroblast under central surveillance. Science, 2000, 289, 1501-1504.
24. Wilson, A ; Trumpp, A. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol, 2006, 6, 93-106.
25. Zimmermann, S; Voss, M; Kaiser, S; Kapp, U; Waller, CF; Martens, UM. Lack of telomerase activity in human mesenchymal stem cells. Leukemia, 2003, 17, 1146-1149.
26. Moore, KA; Lemischka, IR. Stem cells and their niches. Science, 2006, 311, 1880-1885.
27. Bianco, P ; Robey, PG. Stem cells in tissue engineering. Nature, 2001, 414, 118-121.
28. Bianchi, G; Muraglia, A; Daga, A; Corte, G; Cancedda, R; Quarto, R. Microenvironment and stem properties of bone marrow-derived mesenchymal cells. Wound Repair Regen, 2001, 9, 460-466.
29. Kortesidis, A; Zannettino, A; Isenmann, S; Shi, S; Lapidot, T; Gronthos, S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood, 2005, 105, 3793-3801.
30. Goldring, MB; Tsuchimochi, K; Ijiri, K. The control of chondrogenesis. J. Cell Biochem, 2006, 97, 33-44.
31. Kronenberg, HM. Developmental regulation of the growth plate. Nature, 2003, 423, 332-336.
32. Lefebvre, V; Smits, P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res. C Embryo Today, 2005, 75, 200-212.
33. Olsen, BR. Role of cartilage collagens in formation of the skeleton. Ann. N. Y. Acad. Sci, 1996, 785, 124-130.
34. Quintana, L; zur Nieden, NI; Semino, CE. Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering. Tissue Eng. Part B Rev, 2009, 15, 29-41.
35. Olsen, BR; Reginato, AM; Wang, W. Bone development. Annu. Rev. Cell Dev. Biol, 2000, 16, 191-220.
36. DeLise, AM ; Tuan, RS. Alterations in the spatiotemporal expression pattern and function of N-cadherin inhibit cellular condensation and chondrogenesis of limb mesenchymal cells in vitro. J. Cell Biochem, 2002, 87, 342-359.
37. DeLise, AM ; Tuan, RS. Analysis of N-cadherin function in limb mesenchymal chondrogenesis in vitro. Dev. Dyn, 2002, 225, 195-204.
38. Woods, A; Wang, G; Dupuis, H; Shao, Z; Beier, F. Rac1 signaling stimulates N-cadherin expression, mesenchymal condensation, and chondrogenesis. J. Biol. Chem, 2007, 282, 23500-23508.
39. Modarresi, R; Lafond, T; Roman-Blas, JA; Danielson, KG; Tuan, RS; Seghatoleslami, MR. N-cadherin mediated distribution of beta-catenin alters MAP kinase and BMP-2 signaling on chondrogenesis-related gene expression. J. Cell Biochem, 2005, 95, 53-63.
40. Woitge, HW ; Seibel, MJ. Molecular markers of bone and cartilage metabolism. Curr. Opin. Rheumatol, 1999, 11, 218-225.
41. Kondo, S; Shukunami, C; Morioka, Y; Matsumoto, N; Takahashi, R; Oh, J; Atsumi, T; Umezawa, A; Kudo, A; Kitayama, H; Hiraki, Y; Noda, M. Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells. J. Cell Sci, 2007, 120, 849-857.
42. Sahar, DE; Longaker, MT; Quarto, N. Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev. Biol, 2005, 280, 344-361.
43. Jin, EJ; Choi, YA; Kyun, PE; Bang, OS; Kang, SS. MMP-2 functions as a negative regulator of chondrogenic cell condensation via down-regulation of the FAK-integrin beta1 interaction. Dev. Biol, 2007, 308, 474-484.
44. Zhou, Z; Apte, SS; Soininen, R; Cao, R; Baaklini, GY; Rauser, RW; Wang, J; Cao, Y; Tryggvason, K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. U S A, 2000, 97, 4052-4057.
45. Kamiya, N; Watanabe, H; Habuchi, H; Takagi, H; Shinomura, T; Shimizu, K; Kimata, K. Versican/PG-M regulates chondrogenesis as an extracellular matrix molecule crucial for mesenchymal condensation. J. Biol. Chem, 2006, 281, 2390-2400.
46. Gustafsson, E; Aszodi, A; Ortega, N; Hunziker, EB; Denker, HW; Werb, Z; Fassler, R. Role of collagen type II and perlecan in skeletal development. Ann. N. Y. Acad. Sci, 2003, 995, 140-150.
47. French, MM; Smith, SE; Akanbi, K; Sanford, T; Hecht, J; Farach-Carson, MC; Carson, DD. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J. Cell Biol, 1999, 145, 1103-1115.
48. Whitelock, JM; Melrose, J; Iozzo, RV. Diverse cell signaling events modulated by perlecan. Biochemistry, 2008, 47, 11174-11183.
49. Ornitz, DM. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays, 2000, 22, 108-112.
50. Takada, T; Katagiri, T; Ifuku, M; Morimura, N; Kobayashi, M; Hasegawa, K; Ogamo, A; Kamijo, R. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem, 2003, 278, 43229-43235.
51. Aszodi, A; Bateman, JF; Gustafsson, E; Boot-Handford, R; Fassler, R. Mammalian skeletogenesis and extracellular matrix: what can we learn from knockout mice? Cell Struct. Funct, 2000, 25, 73-84.
52. Arikawa-Hirasawa, E; Watanabe, H; Takami, H; Hassell, JR; Yamada, Y. Perlecan is essential for cartilage and cephalic development. Nat. Genet, 1999, 23, 354-358.
53. Fears, CY ; Woods, A. The role of syndecans in disease and wound healing. Matrix Biol, 2006, 25, 443-456.
54. Echtermeyer, F; Bertrand, J; Dreier, R; Meinecke, I; Neugebauer, K; Fuerst, M; Lee, YJ; Song, YW; Herzog, C; Theilmeier, G; Pap, T. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat. Med, 2009, 15, 1072-1076.
55. Fisher, MC; Li, Y; Seghatoleslami, MR; Dealy, CN; Kosher, RA. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol, 2006, 25, 27-39.
56. Hagg, R; Bruckner, P; Hedbom, E. Cartilage fibrils of mammals are biochemically heterogeneous: differential distribution of decorin and collagen IX. J. Cell Biol, 1998, 142, 285-294.
57. Mendler, M; Eich-Bender, SG; Vaughan, L; Winterhalter, KH; Bruckner, P. Cartilage contains mixed fibrils of collagen types II, IX, and XI. J. Cell Biol, 1989, 108, 191-197.
58. Kassner, A; Hansen, U; Miosge, N; Reinhardt, DP; Aigner, T; Bruckner-Tuderman, L; Bruckner, P; Grassel, S. Discrete integration of collagen XVI into tissue-specific collagen fibrils or beaded microfibrils. Matrix Biol, 2003, 22, 131-143.
59. Hedbom, E ; Heinegard, D. Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem, 1993, 268, 27307-27312.
60. Poole, CA. Articular cartilage chondrons: form, function and failure. J. Anat, 1997, 191 (Pt 1), 1-13.
61. Poole, AR; Kojima, T; Yasuda, T; Mwale, F; Kobayashi, M; Laverty, S. Composition and structure of articular cartilage: a template for tissue repair. Clin. Orthop. Relat. Res, 2001, 391 Suppl, S26-S33.
62. Wiberg, C; Klatt, AR; Wagener, R; Paulsson, M; Bateman, JF; Heinegard, D; Morgelin, M. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J. Biol. Chem, 2003, 278, 37698-37704.
63. Bruckner, P; Mendler, M; Steinmann, B; Huber, S; Winterhalter, KH. The structure of human collagen type IX and its organization in fetal and infant cartilage fibrils. J. Biol. Chem, 1988, 263, 16911-16917.
64. Vaughan, L; Mendler, M; Huber, S; Bruckner, P; Winterhalter, KH; Irwin, MI; Mayne, R. D-periodic distribution of collagen type IX along cartilage fibrils. J. Cell Biol, 1988, 106, 991-997.
65. Budde, B; Blumbach, K; Ylostalo, J; Zaucke, F; Ehlen, HW; Wagener, R; Ala-Kokko, L; Paulsson, M; Bruckner, P; Grassel, S. Altered Integration of Matrilin-3 into Cartilage Extracellular Matrix in the Absence of Collagen IX. Mol. Cell Biol, 2005, 25, 10465-10478.
66. Dreier, R; Opolka, A; Grifka, J; Bruckner, P; Grassel, S. Collagen IX-deficiency seriously compromises growth cartilage development in mice. Matrix Biol, 2008, 27, 319-329.
67. Blumbach, K; Niehoff, A; Paulsson, M; Zaucke, F. Ablation of collagen IX and COMP disrupts epiphyseal cartilage architecture. Matrix Biol, 2008, 27, 306-318.
68. Aszodi, A; Hunziker, EB; Brakebusch, C; Fassler, R. Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes. Dev, 2003, 17, 2465-2479.
69. Bengtsson, T; Aszodi, A; Nicolae, C; Hunziker, EB; Lundgren-Akerlund, E; Fassler, R. Loss of alpha10beta1 integrin expression leads to moderate dysfunction of growth plate chondrocytes. J. Cell Sci, 2005, 118, 929-936.
70. Kapyla, J; Jaalinoja, J; Tulla, M; Ylostalo, J; Nissinen, L; Viitasalo, T; Vehvilainen, P; Marjomaki, V; Nykvist, P; Saamanen, AM; Farndale, RW; Birk, DE; Ala-Kokko, L; Heino, J. The fibril-associated collagen IX provides a novel mechanism for cell adhesion to cartilaginous matrix. J. Biol. Chem, 2004, 279, 51677-51687.
71. Makihira, S; Yan, W; Ohno, S; Kawamoto, T; Fujimoto, K; Okimura, A; Yoshida, E; Noshiro, M; Hamada, T; Kato, Y. Enhancement of cell adhesion and spreading by a cartilage-specific noncollagenous protein, cartilage matrix protein (CMP/Matrilin-1), via integrin alpha1beta1. J. Biol. Chem, 1999, 274, 11417-11423.
72. Chen, FH; Thomas, AO; Hecht, JT; Goldring, MB; Lawler, J. Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J. Biol. Chem, 2005, 280, 32655-32661.
73. Grashoff, C; Aszodi, A; Sakai, T; Hunziker, EB; Fassler, R. Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep, 2003, 4, 432-438.
74. Wang, G; Woods, A; Agoston, H; Ulici, V; Glogauer, M; Beier, F. Genetic ablation of Rac1 in cartilage results in chondrodysplasia. Dev. Biol, 2007, 306, 612-623.
75. Zaucke, F ; Grassel, S. Genetic mouse models for the functional analysis of the perifibrillar components collagen IX, COMP and matrilin-3: Implications for growth cartilage differentiation and endochondral ossification. Histol. Histopathol, 2009, 24, 1067-1079.
76. Williams, CG; Kim, TK; Taboas, A; Malik, A; Manson, P; Elisseeff, J. In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng, 2003, 9, 679-688.
77. Alhadlaq, A; Elisseeff, JH; Hong, L; Williams, CG; Caplan, AI; Sharma, B; Kopher, RA; Tomkoria, S; Lennon, DP; Lopez, A; Mao, JJ. Adult stem cell driven genesis of human-shaped articular condyle. Ann. Biomed. Eng, 2004, 32, 911-923.
78. Jikko, A; Kato, Y; Hiranuma, H; Fuchihata, H. Inhibition of chondrocyte terminal differentiation and matrix calcification by soluble factors released by articular chondrocytes. Calcif. Tissue Int, 1999, 65, 276-279.
79. D'Angelo, M ; Pacifici, M. Articular chondrocytes produce factors that inhibit maturation of sternal chondrocytes in serum-free agarose cultures: a TGF-beta independent process. J. Bone Miner Res, 1997, 12, 1368-1377.
80. Babarina, AV; Mollers, U; Bittner, K; Vischer, P; Bruckner, P. Role of the subchondral vascular system in endochondral ossification: endothelial cell-derived proteinases derepress late cartilage differentiation in vitro. Matrix Biol, 2001, 20, 205-213.
81. Bittner, K; Vischer, P; Bartholmes, P; Bruckner, P. Role of the subchondral vascular system in endochondral ossification: endothelial cells specifically derepress late differentiation in resting chondrocytes in vitro. Exp. Cell Res, 1998, 238, 491-497.
82. Bohme, K; Winterhalter, KH; Bruckner, P. Terminal differentiation of chondrocytes in culture is a spontaneous process and is arrested by transforming growth factor-beta 2 and basic fibroblast growth factor in synergy. Exp. Cell Res, 1995, 216, 191-198.
83. Dreier, R; Wallace, S; Fuchs, S; Bruckner, P; Grassel, S. Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9). J. Cell Sci, 2001, 114, 3813-3822.
84. Dreier, R; Grassel, S; Fuchs, S; Schaumburger, J; Bruckner, P. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp. Cell Res, 2004, 297, 303-312.
85. Knauper, V; Bailey, L; Worley, JR; Soloway, P; Patterson, ML; Murphy, G. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13. FEBS Lett, 2002, 532, 127-130.
86. Pufe, T; Bartscher, M; Petersen, W; Tillmann, B; Mentlein, R. Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. Osteoarthritis Cartilage, 2003, 11, 260-264.
87. Sanchez, C; Deberg, MA; Piccardi, N; Msika, P; Reginster, JY; Henrotin, YE. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage, 2005, 13, 979-987.
88. Sanchez, C; Deberg, MA; Piccardi, N; Msika, P; Reginster, JY; Henrotin, YE. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis Cartilage, 2005, 13, 988-997.
89. Ahmed, N; Dreier, R; Gopferich, A; Grifka, J; Grassel, S. Soluble signalling factors derived from differentiated cartilage tissue affect chondrogenic differentiation of rat adult marrow stromal cells. Cell Physiol. Biochem, 2007, 20, 665-678.
90. Inada, M; Wang, Y; Byrne, MH; Rahman, MU; Miyaura, C; Lopez-Otin, C; Krane, SM. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. U S A, 2004, 101, 17192-17197.
91. Stickens, D; Behonick, DJ; Ortega, N; Heyer, B; Hartenstein, B; Yu, Y; Fosang, AJ; Schorpp-Kistner, M; Angel, P; Werb, Z. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development, 2004, 131, 5883-5895.
92. Jiang, J; Nicoll, SB; Lu, HH. Co-culture of osteoblasts and chondrocytes modulates cellular differentiation in vitro. Biochem. Biophys. Res. Commun, 2005, 338, 762-770.
93. Richardson, SM; Walker, RV; Parker, S; Rhodes, NP; Hunt, JA; Freemont, AJ; Hoyland, JA. Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cells, 2006, 24, 707-716.
94. Le Visage, C; Kim, SW; Tateno, K; Sieber, AN; Kostuik, JP; Leong, KW. Interaction of human mesenchymal stem cells with disc cells: changes in extracellular matrix biosynthesis. Spine, 2006, 31, 2036-2042.
95. Yang, HN; Park, JS; Na, K; Woo, DG; Kwon, YD; Park, KH. The use of green fluorescence gene (GFP)-modified rabbit mesenchymal stem cells (rMSCs) co-cultured with chondrocytes in hydrogel constructs to reveal the chondrogenesis of MSCs. Biomaterials, 2009, 30, 6374-6385.
96. Chen, WH; Lai, MT; Wu, AT; Wu, CC; Gelovani, JG; Lin, CT; Hung, SC; Chiu, WT; Deng, WP. In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes. Arthritis Rheum, 2009, 60, 450-459.
97. Gan, L ; Kandel, RA. In Vitro Cartilage Tissue Formation by Co-culture of Primary and Passaged Chondrocytes. Tissue Eng, 2007, 13, 831-842.
98. Guillotin, B; Bourget, C; Remy-Zolgadri, M; Bareille, R; Fernandez, P; Conrad, V; Amedee-Vilamitjana, J. Human primary endothelial cells stimulate human osteoprogenitor cell differentiation. Cell Physiol. Biochem, 2004, 14, 325-332.
99. Johnstone, B ; Yoo, JU. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin. Orthop. Relat. Res, 1999, 367, S156-S162.
100. Knutsen, G; Engebretsen, L; Ludvigsen, TC; Drogset, JO; Grontvedt, T; Solheim, E; Strand, T; Roberts, S; Isaksen, V; Johansen, O. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J. Bone Joint Surg. Am, 2004, 86-A, 455-464.
101. Brittberg, M; Lindahl, A; Nilsson, A; Ohlsson, C; Isaksson, O; Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med, 1994, 331, 889-895.
102. Nakahara, H; Goldberg, VM; Caplan, AI. Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J. Orthop. Res, 1991, 9, 465-476.
103. O'Driscoll, SW; Recklies, AD; Poole, AR. Chondrogenesis in periosteal explants. An organ culture model for in vitro study. J. Bone Joint. Surg. Am, 1994, 76, 1042-1051.
104. Grassel, S ; Ahmed, N. Influence of cellular microenvironment and paracrine signals on chondrogenic differentiation. Front Biosci, 2007, 12, 4946-4956.
105. Ferguson, C; Alpern, E; Miclau, T; Helms, JA. Does adult fracture repair recapitulate embryonic skeletal formation? Mech. Dev, 1999, 87, 57-66.
106. Gerstenfeld, LC; Cullinane, DM; Barnes, GL; Graves, DT; Einhorn, TA. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell Biochem, 2003, 88, 873-884.
107. Glennie, S; Soeiro, I; Dyson, PJ; Lam, EW; Dazzi, F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 2005, 105, 2821-2827.
108. Corcione, A; Benvenuto, F; Ferretti, E; Giunti, D; Cappiello, V; Cazzanti, F; Risso, M; Gualandi, F; Mancardi, GL; Pistoia, V; Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood, 2006, 107, 367-372.
109. Alsalameh, S; Amin, R; Gemba, T; Lotz, M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum, 2004, 50, 1522-1532.
110. Grogan, SP; Miyaki, S; Asahara, H; D'Lima, DD; Lotz, MK. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthritis Res. Ther, 2009, 11, R85-102
111. Dowthwaite, GP; Bishop, JC; Redman, SN; Khan, IM; Rooney, P; Evans, DJ; Haughton, L; Bayram, Z; Boyer, S; Thomson, B; Wolfe, MS; Archer, CW. The surface of articular cartilage contains a progenitor cell population. J. Cell Sci, 2004, 117, 889-897.
112. Barry, FP. Biology and clinical applications of mesenchymal stem cells. Birth Defects Res. C. Embryo Today, 2003, 69, 250-256.
113. Pelttari, K; Steck, E; Richter, W. The use of mesenchymal stem cells for chondrogenesis. Injury, 2008, 39 Suppl 1, S58-S65.